CANCER 2026 , ,
Presentations this author is a contributor to:
Expanding the utility of PARP inhibitors using combination therapy with androgen receptor signalling inhibitors in prostate cancer (#245)
5:35 PM
Mahsa Rostamiandelavar
Poster Session 2